The phenomenon of cancer recurrence remains one of the most significant challenges in modern oncology, particularly in the context of…
Read More

The phenomenon of cancer recurrence remains one of the most significant challenges in modern oncology, particularly in the context of…
Read More
Novartis has announced a significant strategic move to bolster its oncology pipeline with the acquisition of SNV4818, an investigational oral…
Read More